Skip to main content
All lobbying filings

CAPITOL ASSOCIATES, INC.

Lobbying for JOINT COUNCIL OF ALLERGY ASTHMA & IMMUNOLOGY D/B/A ADVOCACY COUNCIL OF ACAAI

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Illinois

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

CoFAR and DOD Food Allergy Research Funding 2026 Appropriations

Medicare reimbursements for physicians Prior Authorization Reform H.R.2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 Medicare Advantage burden reduction reform One Big Beautiful Bill Act S. 1105 - No Upcode Act Medicare coverage for allergy immunotherapy Protecting Approved Care Act Patients First Act

Protecting Children with Food Allergies Act Telehealth coverage flexibilities Epinephrine costsharing for patients Asthma inhaler prices Cybersecurity requirements for medical practices No Fees for EFTs Act Supporting food allergy treatment innovations Smoke and Wildfire HR 903 One Big Beautiful Bill Act S.1816/H.R.3514 Coverage for allergy immunotherapy EPIPEN Act S. 222 Whole Milk for Healthy Kids Act Biosimilar/Biologic Approval Process

Epinephrine for anaphylaxis on commercial airline emergency medical kits

 Bills named in this filing 6
  • H.R. 2433
    Reducing Medically Unnecessary Delays in Care Act of 2025
  • S. 1105
    No UPCODE Act
  • H.R. 903
    Smoke and Heat Ready Communities Act of 2025
  • S. 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • H.R. 3514
    Humane Correctional Health Care Act
  • S. 222
    Whole Milk for Healthy Kids Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem